Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer.
about
Ovarian Cancer: The Fallopian Tube as the Site of Origin and Opportunities for PreventionThe lack of clinical value of peritoneal washing cytology in high risk patients undergoing risk-reducing salpingo-oophorectomy: a retrospective study and reviewRationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the EvidenceDistinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification.The preclinical natural history of serous ovarian cancer: defining the target for early detectionIMP3 as a cytoplasmic biomarker for early serous tubal carcinogenesisHereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.The fallopian tube: from back stage to center stage.A case of non-invasive serous adenocarcinoma at unilateral fimbria with spread to the peritoneal/uterine cavity: case report.Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer.Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesisGonadotropins activate oncogenic pathways to enhance proliferation in normal mouse ovarian surface epithelium.Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions.Molecular pathogenesis of endometrial and ovarian cancer.Peritoneal washing cytology in patients with BRCA1 or BRCA2 mutations undergoing risk-reducing salpingo-oophorectomies: a 10-year experience and reappraisal of its clinical utility.BRCA and Early Events in the Development of Serous Ovarian Cancer.Primary fallopian tube carcinoma arising in the setting of chronic pelvic inflammatory disease.Refractory fallopian tube carcinoma - current perspectives in pathogenesis and management.The role of the fallopian tube in the origin of ovarian cancer.Advances in serous tubal intraepithelial carcinoma: correlation with high grade serous carcinoma and ovarian carcinogenesis.Key features of extrauterine pelvic serous tumours (fallopian tube, ovary, and peritoneum).Molecular pathogenesis of ovarian clear cell carcinoma.Identification of abrogated pathways in fallopian tube epithelium from BRCA1 mutation carriers.High-grade serous carcinoma of tubo-ovarian origin: recent developments.Müllerian intra-abdominal carcinomatosis in hereditary breast ovarian cancer syndrome: implications for risk-reducing surgery.Tubal origin of ovarian cancer - the double-edged sword of haemoglobin.Detection of serous precursor lesions in resected fallopian tubes from patients with benign diseases and a relatively low risk for ovarian cancer.Gene expression analysis identifies two groups of ovarian high-grade serous carcinomas with different prognosis.Ki-67 and p53 expression of the fallopian tube mucosa in breast cancer patients with hereditary risk.Chirurgie annexielle prophylactique des femmes à risque héréditaire : vers de nouvelles pistes ?
P2860
Q26747279-88D944AE-F8FD-41AA-9F50-16E7C49558F3Q28077192-8804019A-AB38-4A63-AA27-A1232F5A1C7AQ30250107-84E101EF-E6C1-4758-B02C-97DFDE26836AQ31141440-2016DED3-D430-4450-A826-8D4E988B4BB8Q33487678-B9617A9E-678E-4DB8-9C9D-2954AC82F2CFQ34468574-64B8F147-589B-488B-AE23-0639566EE904Q34977063-F1A16563-7232-4FCE-B4EE-A06D6261C0C1Q35562911-A454A669-ACEB-46E6-85AF-21AB8C59C768Q35575368-D398EFD8-1E56-4BD3-8344-5E8959DDB03DQ35758403-F904BD6F-0DE3-4974-B040-2B924BDC42EAQ36652107-95E3F34D-90A4-445C-B02A-F894465C9F19Q36790475-1437995C-78C9-4BCC-AC4A-DF1192B65FFFQ37257654-D58DCDE2-C8E9-4E39-AB3E-2BF4FF519F1DQ37293672-789A3708-6F5D-4BD8-9ECA-AB673F05382CQ37416391-7AA99D4E-0CDE-4A19-B344-CBA243E98F36Q37513137-33E96F5F-06D8-4F93-86E7-BB96B36E28FBQ37553928-2CA95CAD-AFA7-49F9-9A98-9DDED67F722DQ37553978-58D37E2E-7995-4148-BC34-EE02D35288D0Q37608093-847A2EF4-F701-4149-8F0E-E9C194DA9596Q37676705-59437907-7010-4D57-B0F4-FD41A667D4E4Q37988903-2A36FC58-C6C2-43A9-B9B8-0AB39AE91568Q38465850-FE9626A2-9D19-417C-A3D9-D1375B8C18CAQ38501477-B77AE14A-9049-4687-8BCA-07631A2D3CC6Q38687061-201E74DA-9C26-4BDD-B7A3-F085CBAA5CC5Q38732720-B6509A44-56DB-4374-A2C0-5B2A12177469Q39068123-0611DEC1-599A-4C2B-BB4F-D9FCA2B4D227Q39718281-990392B4-F432-44EE-A3C3-E4A115781F34Q46560077-E237BC25-1557-4F93-AFA3-2CF4810D2498Q54653872-A3265A16-AC70-49EE-8758-A2B5820110E4Q58356251-14EB18FF-564F-4315-9532-32D4EC04F664
P2860
Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Advances in the recognition of ...... athogenesis of ovarian cancer.
@ast
Advances in the recognition of ...... athogenesis of ovarian cancer.
@en
type
label
Advances in the recognition of ...... athogenesis of ovarian cancer.
@ast
Advances in the recognition of ...... athogenesis of ovarian cancer.
@en
prefLabel
Advances in the recognition of ...... athogenesis of ovarian cancer.
@ast
Advances in the recognition of ...... athogenesis of ovarian cancer.
@en
P2093
P1476
Advances in the recognition of ...... athogenesis of ovarian cancer.
@en
P2093
Christopher P Crum
David Kindelberger
Fabiola Medeiros
Michael G Muto
Michael J Callahan
Yonghee Lee
P356
10.1097/01.PAP.0000201826.46978.E5
P577
2006-01-01T00:00:00Z